This complication occurs in up to 44% of patients with systemic lupus erythematosus.
Reference1. Hussein S, Suitner M, BÃ©land-Bonenfant S, et al. Monitoring of osteonecrosis in systemic lupus erythematosus patients: a systematic review and metaanalysis. J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi:10.3899/jrheum.170837. [Epub ahead of print]
Hussein and colleagues in Canada have discovered a potentially strong association between corticosteroid use in systemic lupus erythematosus (SLE) and osteonecrosis.1 Scroll through the slides for the details of the study and the take-home points for physicians.
(Image credit: ©ImagePointFr/Shutterstock.com)